Skip to main content

Moderna ramps up manufacturing capacity to 1.4B doses for 2022

Cambridge biotech Moderna is increasing its manufacturing capacity of the Covid-19 vaccine over the next two years: to 700 million doses in 2021, up from 600 million, and to 1.4 billion doses in 2022. The company is also exploring whether its coronavirus vaccine can be administered at a lower dose.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.